About Olmesartan Medoxomil
Class: | Angiotensin II receptor antagonist (ARB)
Use: | Treatment of hypertension; may be used alone or in combination with other antihypertensive agents
Adult dose: | Initial dose: 20 mg once daily; may be increased to 40 mg once daily based on blood pressure response
Pediatric dose: | Not established for children under 6 years; for children 6 years and older, the recommended dose is 0.3 mg/kg (up to a maximum of 20 mg) once daily
Side effects: | Dizziness, headache, fatigue, diarrhea,
Drug Class
Angiotensin II receptor antagonist (ARB)
Uses & Indications
Treatment of hypertension; may be used alone or in combination with other antihypertensive agents
Storage Requirements
Store at room temperature (20-25°C or 68-77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: Laboratorios Cinfa S.A, SPAIN
Package Size
28s
Price & Supplier
Price in UAE: AED 38.00
Dosage Information
Adult Dose
Initial dose: 20 mg once daily; may be increased to 40 mg once daily based on blood pressure response
Pediatric Dose
Not established for children under 6 years; for children 6 years and older, the recommended dose is 0.3 mg/kg (up to a maximum of 20 mg) once daily
Side Effects
Dizziness, headache, fatigue, diarrhea, nausea, and upper respiratory infections
Contraindications & Precautions
Hypersensitivity to olmesartan or any component of the formulation; pregnancy; severe hepatic impairment; bilateral renal artery stenosis
Important Warnings
Risk of hypotension in volume-depleted patients; monitor renal function; may cause fetal harm if used during pregnancy; not recommended for use in patients with a history of angioedema related to ACE inhibitors or ARBs
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.